8-K

                        UNITED STATES
             SECURITIES AND EXCHANGE COMMISSION
                   Washington, D.C. 20549
                         __________

                          FORM 8-K

                       CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 1, 2005
                                                  --------------

                    PETMED EXPRESS, INC.
    ----------------------------------------------------
   (Exact name of registrant as specified in its charter)

              Commission file number 000-28827
                                     ---------

           FLORIDA                            65-0680967
   ---------------------------               ------------
  (State or other jurisdiction              (IRS Employer
of incorporation or organization)         Identification No.)


1441 S.W. 29th Avenue, Pompano Beach, Florida       33069
- ---------------------------------------------      --------
  (Address of principal executive offices)        (Zip Code)

Registrant's telephone number, including area code: (954) 979-5995
                                                    --------------

                        Not Applicable
 -----------------------------------------------------------
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:

[   ] Written communications pursuant to Rule 425 under the
      Securities Act

[   ] Soliciting material pursuant to Rule 14a-12 under the
      Exchange Act

[   ] Pre-commencement communications pursuant to Rule 14d-2(b)
      under the Exchange Act

[   ] Pre-commencement communications pursuant to Rule 13e-4(c)
      under the Exchange Act





Item 1.01  Entry into a Material Definitive Agreement

Item 1.02  Termination of a Material Definitive Agreement

     On August 1, 2005, the Company and Marc Puleo, M.D. mutually
agreed  to  terminate  his Executive Employment  Agreement.   Dr.
Puleo  will no longer serve as the Company's President.  He  will
remain employed by the Company at his current salary of $150,000.
His  current position as Chairman of the Board of Directors  (and
as  a director), remains unaffected by this agreement.  Dr. Puleo
will  continue  to assist the Company with its marketing  efforts
and  media buying.  Menderes Akdag, the Company's Chief Executive
Officer will assume the role as the Company's President.

     A copy of this Executive Employment Termination Agreement is
attached  hereto as Exhibit 10.13 and is incorporated  herein  by
reference.

Item 9.01 Financial Statements and Exhibits

     (c)  Exhibits

10.13   Marc Puleo, M.D. Executive Employment Termination Agreement



                         SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.


PETMED EXPRESS, INC.
(The "Registrant")

Date: August 1, 2005

By:  /s/  Menderes Akdag
     ---------------------------
     Menderes Akdag

     Chief Executive Officer and President
     (principal executive officer)

By:  /s/  Bruce S. Rosenbloom
     ----------------------------
     Bruce S. Rosenbloom

     Chief Financial Officer
     (principal financial and accounting officer)






                        EXHIBIT INDEX

Exhibit No.                   Description


10.13     Marc Puleo, M.D. Executive Employment Termination Agreement

EX-10.13

                        EXHIBIT 10.13

August 1, 2005

Marc Puleo, M.D.
PetMed Express, Inc.
1441 SW 29th Avenue
Pompano Beach, FL 33069

Dear Marc:

      Effective as of the date of this letter, this will confirm
the following:

      *the  agreement between you and PetMed  Express,  Inc.
       (the  "Company"),  including,  but  not  limited   to:
       Executive  Employment Agreement dated  May  15,  1997;
       Amendment to Executive Employment Agreement, dated May
       15, 1997; Executive Employment Agreement, dated May 1,
       1998;   Amended  and  Restated  Executive   Employment
       Agreement,  dated  May  1, 1998;  Second  Amended  and
       Restated Executive Employment Agreement, dated May  1,
       2000;   Amendment  to  Second  Amended  and   Restated
       Executive  Employment  Agreement,  dated  November  8,
       2000, is hereby terminated;

      *there are no outstanding payments of any kind due  or
       owed  to you as a result of any employment agreements,
       including  but  not  limited to,  the  above-mentioned
       agreements;

      *you will no longer serve in the position of President
       of the Company;

      *you  agree  that  all  severance  benefits  will   be
       terminated  in exchange for you remaining employed  at
       the  Company  as an at-will employee, at your  current
       salary  of  $150,000,  and  with  all  current  health
       benefits remaining unchanged;

      *your  current position as Chairman of  the  Board  of
       Directors  (and as a director) remains  unaffected  by
       this agreement; and

      *any  options  referred to in any of the above  stated
       employment  agreements likewise remain  unaffected  by
       this agreement.

     IN WITNESS WHEREOF, the parties have executed and delivered
this Agreement as of August 1, 2005.
                                        PETMED EXPRESS, INC.:



/s/   Marc   Puleo,  M.D.              /s/   Mendo Akdag
- --------------------------             ------------------------
MARC PULEO, M.D.                       By: MENDO AKDAG


/s/  Alison Berges                     /s/  Bruce  S. Rosenbloom
- --------------------------             -------------------------
Witness                                Witness


                       10.13 Page 1 - 1